|
|
REVIEW ARTICLE |
|
Year : 2012 | Volume
: 1
| Issue : 4 | Page : 217-223 |
|
Polymeric nanoparticles for drug delivery and targeting: A comprehensive review
Natarajan Jawahar1, SN Meyyanathan2
1 Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund, Tamil Nadu, India 2 Department of Pharmaceutical Analysis, JSS College of Pharmacy, Ootacamund, Tamil Nadu, India
Date of Web Publication | 27-Feb-2013 |
Correspondence Address: Natarajan Jawahar Department of Pharmaceutics, JSS College of Pharmacy, Ootacamund - 643 001, Tamil Nadu India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/2278-344X.107832
In the recent years, many modern technologies have been established in the pharmaceutical research and development area. The field of nanotechnology has been revolutionary as substantial and technical, and scientific growth, in basic sciences plus manipulation by physical or chemical process of individual atoms and molecules have widened its horizon. Polymeric nanoparticles with a size in the nanometer range protect drugs against in vitro and in vivo degradation; it releases the drug in a controlled manner and also offers the possibility of drug targeting. The use of polymeric drug nanoparticles is a universal approach to increase the therapeutic performance of poorly soluble drugs in any route of administration. The present review discusses the physico-chemical properties of polymeric nanoparticles, production methods, routes of administration and potential therapeutic applications. Keywords: Drug delivery, drug release kinetics, nanoparticles, physico-chemical characteristics, targeting
How to cite this article: Jawahar N, Meyyanathan S N. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review. Int J Health Allied Sci 2012;1:217-23 |
How to cite this URL: Jawahar N, Meyyanathan S N. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review. Int J Health Allied Sci [serial online] 2012 [cited 2024 Mar 28];1:217-23. Available from: https://www.ijhas.in/text.asp?2012/1/4/217/107832 |
Introduction | | |
Technological advancements have brought about many new innovative drug delivery systems. Polymeric nanoparticulate systems from biodegradable and biocompatible polymers are interesting options for controlled drug delivery and drug targeting. [1],[2],[3] Polymeric nanoparticles are solid colloidal particles with diameter ranging from 1 to 1000 nm. [1] They have been investigated especially in drug delivery and drug targeting owing to their particle size and long circulation in the blood. [4],[5] They consist of macromolecular materials and can be used therapeutically as adjuvant in vaccines or drug carriers in which the active ingredient is dissolved, entrapped, encapsulated, adsorbed or chemically attached. [6]
Advantages | | |
The advantages of using nanoparticles as a drug delivery system include the following:
- Controlled and sustained release of the drug during transportation and at the site of localisation, altering the organ distribution of the drug and subsequent clearance of the drug so as to achieve increase in drug therapeutic efficacy and reduction in side effects.
- Decreased toxicity and occurrence of adverse drug reactions.
- Better drug utilisation.
- Site-specific targeting can be achieved by attaching targeting ligands to the surface of the particles or through use of magnetic guidance.
- The system can be used for various routes of administration, including oral, nasal, parenteral, intra-ocular, etc.
Limitations | | |
In spite of these advantages, nanoparticles have some limitations. Due to their smaller size and large surface area:
- Particle-particle aggregation makes physical handling of nanoparticles difficult in liquid and dry form.
Types of Nanoparticles | | |
There are two types of nanoparticles depending on the preparation processes:
The term nanoparticles are a collective name for both nanospheres and nanocapsules.
Nanospheres have a monolithic-type structure (matrix) in which drugs are dispersed or adsorbed onto their surfaces or encapsulated within the particles.
Nanocapsules are the vesicular system in which the drug is confined to a cavity consisting of an inner liquid core surrounded by a polymeric membrane. In this case the active substance is usually dissolved in the inner core, but may also be adsorbed to the capsule surface [Figure 1]. [7]
Criteria for Ideal Polymeric Carrier for Nanoparticles | | |
The criteria for the ideal polymeric carrier for nanoparticles are [7] as follows:
- Easy to synthesise and characterise
- Inexpensive
- Biocompatible
- Biodegradable
- Non-immunogenic
- Non-toxic
- Water-soluble
Carriers Used in the Preparation of Nanopaticles
The polymers used for preparation of nanoparticles are as follows:
- Natural hydrophilic polymer
- Synthetic hydrophobic polymer
Natural hydrophilic polymer
Natural hydrophilic polymers such as proteins (gelatine, albumin, lecithin, legumin and vicillin) and polysaccharides (alginate, dextran, chitosan, agarose and pullulan) are widely used. But these polymers have certain disadvantages such as poor batch-to-batch reproductivity, the specific conditions for their degradation and potential antigenicity.
Synthetic hydrophobic polymer
These polymers are divided into two groups: The first group includes polyesters (poly (€ -caprolactone), poly (lactic acid), poly (lactide-co-glycolide), polystyrene) and the second group includes poly (alkyl cyanoacrylates) (poly (isobutyl cyanoacrylates), poly (butylcyanoacrylates), poly methyl (methcyanoacrylates)).
Preparation of Nanoparticles | | |
Ionic gelation
In this method, chitosan is dissolved in an aqueous acidic solution to obtain the cation of chitosan. This solution is then added dropwise under constant stirring to a poly anionic tripolyphosphate (TPP) solution. Due to complexation between oppositely charged species, chitosan undergoes ionic gelation and precipitates to form spherical particles. Three kinds of phenomena were observed: Solution, aggregation and opalescent suspension. The resulting chitosan particle suspension was subsequently centrifuged and dried. [8]
Nanoprecipitation
Nanoparticle formation is instantaneous and the entire procedure is carried out in only one step. Briefly, it requires two solvents that are miscible. Ideally, both the polymer and the drug must dissolve in the first one (the solvent) but not in the second system (the non-solvent). Nanoprecipitation occurs by rapid desolvation of the polymer when the polymer solution is added to the non-solvent. [9],[10],[11]
Emulsion cross-linking method
In this method, a water-in-oil (w/o) emulsion is prepared by emulsifying the chitosan solution in the oil phase. Aqueous droplets are stabilised using a suitable surfactant; the stable emulsion is cross-linked by an appropriate cross-linking agent such as glutaraldehyde to harden the droplets, and the particles are filtered and washed repeatedly. By this method particle size can be controlled by controlling the size of the aqueous droplets. However, the particle size of the final product depends upon the extent of the cross-linking agent used while hardening in addition to the speed of stirring during the formation of emulsion. The drawback of this method involves tedious procedure as well as use of harsh cross-linking agents, which might possibly induce chemical reactions with the agents; however, complete removal of un-reacted cross-linking agent may be difficult in this process. [12]
Spray-drying
In this method chitosan is first dissolved in acetic acid; the drug is dissolved or dispersed in the solution and then a suitable cross-linking agent is added; this solution or dispersion is then atomised in a stream of hot air. Atomisation leads to the formation of small droplets, from which the solvent evaporates, leading to the formation of free-flowing powders. Particle size depends upon size of the nozzle, spray flow rate, atomisation pressure and inlet air temperature, and extent of cross-linking. [13]
Salting-out method
In this method acetone is chosen as the water-miscible organic solvent because of its pharmaceutical acceptance with regard to toxicity. The method consists of addition of water-soluble polyvinyl alcohol (PVA) in a highly concentrated salt solution in water (aqueous phase) to a polymer solution in acetone (organic phase). Although acetone is miscible with pure water in all ratios, the high salt concentration of the aqueous phase prevents mixing of the phase. After emulsification, addition of pure water in a sufficient quantity causes acetone to diffuse into the aqueous phase, resulting in the formation of nanoparticles. [14]
Pharmaceutical Consideration | | |
Isolation
Nanoparticles are normally isolated by freeze-drying using cryoprotective agents (sugars such as glucose and trehalose) to assess the re-dispersibility of the colloidal system and to prevent the aggregation of nanoparticles during the freeze-drying process. [7]
Purification
Nanoparticles should be free from impurities and the degree of purification depends upon the final purpose of the formulation developed. The most commonly used procedures are gel filtration, ultracentrifugation, centrifugal filtration, dialysis and cross-flow filtration.
Stability
Generally a colloidal suspension is stable and does not tend to separate as a result of slow deposition of particles or due to the mixing tendencies of diffusion and convection. However, some agglomeration can occur. To prevent complete precipitation, it is necessary to incorporate some additives. Chemical integrity of the drug is also a fundamental aspect of the overall stability of nanoparticles. Some other parameters are also crucial for stability, such as the duration of contact with the aqueous environment when the drug is water-soluble; the surrounding pH when the drug degradation is pH-dependent; and light exposure when the drug is light-sensitive. It is observed that the presence of anionic surfactants in the dispersion causes rapid degradation of nanoparticles as they are made up of hydrolytic degradable polymers. The degradation pathway varies from polymer to polymer. However, the common pathways are by erosion of the polymer backbone and cleavage of ester. Hence stability studies are important and can be performed according to the drug and polymer properties. [7]
Physicochemical Characteristics | | |
The physicochemical methods for characterisation of nanoparticles are tabulated [Table 1]. [5],[7]
Drug Loading | | |
Drug loading in the nanoparticulate system can be done by two methods: [5]
- Incorporation method
- Incubation method
Incorporation method: Incorporating at the time of nanoparticle production.
Incubation method: Adsorbing the drug after the formation of nanoparticles by incubating the carrier with the concentrated drug solution.
Both methods result in:
- A solid solution of the drug in the polymers.
- Solid dispersion of the drug in the polymer.
- Surface adsorption of the drug.
- Chemical bonding of the drug in the polymer.
In these systems the drug is physically embedded into the matrix or adsorbed onto the surface. Various methods of loading have been developed to improve the efficiency of loading, which largely depend upon the method of preparation as well as the physiochemical properties of the drug and the polymer. Maximum loading can be achieved by incorporating the drug during the time of formation of particles, but it may get affected by process parameters such as method of preparation, presence of additives, etc.
Drug Release and Release Kinetics | | |
Drug release from the carrier-based particulate system depends upon the cross-linking, morphology, size, density of the particulate system and the physiochemical properties of the drug, as well as presence of adjuvant. [15] In vitro drug release also depends upon pH, polarity and presence of enzymes in the dissolution medium.
The release of drug from the particulate system depends upon three different mechanisms:
- Release from the surface of particles.
- Diffusion through the swollen rubbery matrix.
- Release due to erosion.
In the majority of cases, drug release follows more than one type of mechanism [Figure 2].
Mechanism of drug release from particle system
When it comes in contact with the release medium, the drug instantaneously dissolves, thus affecting its release from the surface. Drug entrapped in the surface layers of the particles also follows this mechanism. This type of drug release leads to a burst effect.
Drug release through diffusion involves three steps:
- Penetration into the particulate system, which causes swelling of the matrix.
- Conversion of the glassy polymer into a rubbery matrix.
- Diffusion of the drug from the rubbery matrix.
Various methods, which can be used to study the in vitro release of drug, are as follows:
- Side-by-side diffusion cells with an artificial or biological membrane.
- Dialysis bag method.
- Ultracentrifugation.
- Centrifugal ultrafiltration.
Administraion of Nanoparticles | | |
The main administration routes for nanoparticles are intravenous injection, subcutaneous or intramuscular injection; peroral administration; and ophthalmic application.
Intravenous administration
Nanoparticles, like other colloidal carriers such as liposome, micro-emulsions and erythrocyte ghosts, are taken up by the reticuloendothelial systems (RES) after intravenous injection and distributed mainly to the liver, spleen and to a lesser degree, the bone marrow; varying amounts can be found in the lungs. All these organs contain sessile, actively phagocytosing cells. Other phagocytosing cells are found in the blood and lymphatic system, and in the endothelial lining of the blood vessels. These cells can take up nanoparticles by varying degrees. The sequence of events during distribution of nanoparticles and their phagocytosis is not currently known. It is believed that immediately after injection, the particles are coated by the serum components, the opsonins, which act as labels to passively target the nanoparticles to certain phagocytic cells.
Passive targeting
Passive targeting refers to the natural distribution pattern of the drug carrier in vivo. Nanoparticle distribution by the above method is called passive targeting. The mechanical entrapment of large microspheres and large nanoparticles agglomerates (>4 μm) by capillary blockage also is referred to as passive targeting. This process can be exploited to target passively to the lungs via the venous supply or to other organs via the appropriate arterial supply. [14]
Active targeting
Active targeting refers to a change in the natural distribution pattern of a carrier particle by deliberate modification of its properties, thereby directing it to specific cells, tissues or organs.
The following methods are mainly used:
- Alteration of the surface properties by coating the nanoparticles with surfactants or macromolecules;
- Incorporation of magnetite particles into the particles and application of magnetic field;
- Alteration of surface charge; and
- Attachment of specific antibiotics to the nanoparticle surface.
The first two methods seem to be promising. Coating of nanoparticles with surfactants for instance can drastically reduce liver uptake from 80% to 30%, and increase in blood concentration can be from 0.14 up to about 40%. Poloxamine 1508 is the principal agent for reducing liver uptake and increasing blood concentration, whereas polysorbate 80 increases the concentration in non-RES organs. Other surfactants such as poloxamer 184 and 407 have a high targeting capacity to the bone marrow. The possibility of bone marrow targeting is size-dependent. [15]
Subcutaneous and intramuscular injection
After subcutaneous and intramuscular injection of 14 C-labelled polymethacrylate nanoparticles in rat, over 99% of the injected radioactivity remains at the injection site. The elimination rate of the administered dose per day in the form of oligomeric components of the nanoparticulate polymer is found to be lesser in the urine and faeces initially and later elimination is found to be more in faeces.
Oral administration
Nanoparticles are retained in the gut of rats and mice up to 6 days. In addition, they are taken up in the intestine and appear in lymph nodes, blood, liver, spleen and at the site of inflammation in the body. Three different mechanisms are possible:
- Intracellular uptake.
- Intracellular-paracellular uptake.
- Uptake via M-cells and Peyer's patches in the gut.
Ophthalmic application
After ophthalmic application to rabbits, polyhexyl cyanoacrylate nanoparticles are eliminated from tears with a half-life of about 15-20 min. Aqueous eye drops, on the other hand, have a half-life of 1-3 min. A small amount of polycyanoacrylate nanoparticles adhere mainly to the conjunctiva, but also to the cornea and to the nictitating membrane of rabbits, and penetrate into the first two layers of the cell layers. [5]
Nanoparticles and targeted drug delivery
The greatest immediate impact of nanotechnologies in cancer therapy is in drug targeting. The therapeutic index of nearly all drugs currently being used can be improved if they are more efficiently delivered to their biological targets through appropriate application of nanotechnologies. In the case of central nervous system cancers (brain tumour), many drugs have difficulty in crossing the blood-brain barrier to attack the tumour. Drug-loaded nanoparticles are able to penetrate this barrier, and have been shown to greatly increase therapeutic concentration of anticancer drugs in brain tumours. [16]
The best way to increase the efficacy and reduce the toxicity of a cancer drug is to direct the drug to its target and maintain its concentration at the site for a sufficient time for therapeutic action to take effect. The efficiency of drug delivery to various parts of the body is directly affected by particle size. Nanostructure-mediated drug delivery, a key technology for realisation of nanomedicine, has the potential to enhance drug bioavailability, improve timed release of drug molecules and enable precision drug targeting. Additional benefits of using targeted nanoscale drug carriers are reduced drug toxicity and more efficient drug distribution. Anatomic features such as the blood-brain barrier, the branching pathways of the pulmonary system and the tight epithelial junctions of the skin make it difficult for drugs to reach many desired physiologic targets. Nanostructured drug carriers help to penetrate or overcome these barriers to drug delivery, and it has been shown that the greatest efficiency for delivery into the pulmonary system is achieved for particle diameter < 100 nm. Greater uptake efficiency has also been shown for gastrointestinal absorption and transcutaneous permeation, with particles about 100 nm and 50 nm in size, respectively. However, such small particles travelling in the pulmonary tract may also have a greater chance of being exhaled. Larger, compartmental or multilayered drug carrier architectures may help with delivery to the pulmonary extremities. For instance, the outer layers of the carrier architecture may be formulated to biodegrade as the carrier travels through the pulmonary tract. As the drug carrier penetrates further into the lung, additional shedding will allow the encapsulated drug to be released. Biodegradable nanoparticles of gelatin and human serum albumin show promise as pulmonary drug carriers.
Advantages of nanostructure-mediated drug delivery include the ability to deliver drug molecules directly into cells and the capacity to target tumours within healthy tissue. Nanoscale drug delivery architectures are able to penetrate tumours due to the discontinuous, or "leaky," nature of the tumour microvasculature, which typically contains pores ranging from 100 to 1000 nm in diameter. The microvasculature of healthy tissue varies by tissue type, but in most tissues, including the heart, brain and lung, there are tight intercellular junctions less than 10 nm. Therefore, tumours within these tissue types can be selectively targeted by creating drug delivery nanostructures greater than the intercellular gap of the healthy tissue but smaller than the pores found within the tumour vasculature. Nanoparticles have already been used for targeted drug delivery, which enables much earlier detection and immediate treatment of cancer. Nanoparticles attached to chemotherapeutic drugs allow them to traverse the blood-brain barrier for brain tumour treatment. In January 2005, a nanoparticle-based drug called Abraxane (paclitaxel protein-bound particles, Abraxis Oncology) was approved by the Food and Drug Administration for breast cancer treatment. Abraxane uses nanoscale particles of the natural protein albumin that can be delivered in the body without the use of solvents.
Therapeutic Applications | | |
The various therapeutic applications of nanoparticles have been shown in [Table 2].
Conclusion | | |
In the past few decades, researchers have studied alternative delivery systems to improve the efficacy of different medicines. Nanotechnology is an exciting novel field with hopes for improvements in wide variety of uses in drug delivery in pharmaceutical research. Polymeric nanoparticles offer a new avenue to achieve drug delivery and drug targeting with newly discovered disease site-specific drugs and existing poorly soluble drugs. Overcoming the obstacles in conventional drug delivery systems, polymeric nanoparticles are anticipated for better application and effective drug delivery, and would ultimately enhance treatment and patient compliance.
References | | |
1. | Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long circulating nanospheres. Science 1994;263:1600-3. [PUBMED] |
2. | Labhasetwar V, Song C, Levy RJ. Nanoparticles drug delivery systems. Adv Drug Deliv Rev 1997;24:63-85. |
3. | Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-E-caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004;278:1-23. [PUBMED] |
4. | Allemann E, Gurny R, Doelker E. Drug loaded nanoparticles-preparation methods and drug targeting tissues. Eur J Pharm Biopharm 1993;39:173-91. |
5. | Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 2006;97:1184-90. [PUBMED] |
6. | Swarbrick J, Boylan J. Bioavailability of drugs and bioequivalence in encyclopedia of pharmaceutical technology. 3rd Edition. Informa Healthcare, USA. 1994;1:164-190 |
7. | Krishna RS, Shivakumar HG, Gowda DV, Banerjee S. Nanoparticles: A novel colloidal drug delivery system. Indian J Educ Res 2006;40:15-21. |
8. | Kesisoglou F, Panmai S, Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631-44. [PUBMED] |
9. | Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release 1999;57:171-85. [PUBMED] |
10. | Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsules formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989;55:R1-4. |
11. | Teeranachaideekul V, Junyaprasert VB, Souto EB, Müller RH. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm 2008;354:227-34. |
12. | Esmaeili F, Ghahremani MH, Esmaeili B, Khoshayand MR, Atyabi F, Dinarvand R. PLGA nanoparticles of different surface properties: Preparation and of their body distribution. Int J Pharm 2008;349:249-55. [PUBMED] |
13. | Sinha S, Muthu MS. Preparation and characterisation of nanoparticles containing an atypical anti-psychotic agent. Nanomedicine (Lond) 2007;2:233-40. |
14. | Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behaviour in vitro and in vivo. J Control Release 2007;119:77-85. [PUBMED] |
15. | Vyas SP, Khar RK. Targeted and controlled drug delivery system. 1 st ed. New Delhi: CBS Publication and Distribution; 2000. p. 1025-38. |
16. | Arayne MS, Sultana N. Nanoparticles in drug delivery for the treatment of cancer. Pak J Pharm Sci 2006;19:258-68. [PUBMED] |
[Figure 1], [Figure 2]
[Table 1], [Table 2]
This article has been cited by | 1 |
Beyond traditional hydrogels: The emergence of graphene oxide-based hydrogels in drug delivery |
|
| Renu Saharan, Sarvesh K. Paliwal, Abhishek Tiwari, M. Arockia Babu, Varsha Tiwari, Randhir Singh, Suresh Kumar Beniwal, Manish Kumar, Ajay Sharma, Waleed Hassan Almalki, Imran Kazmi, Sami I. Alzarea, Neelima Kukreti, Gaurav Gupta | | Journal of Drug Delivery Science and Technology. 2024; : 105506 | | [Pubmed] | [DOI] | | 2 |
A Review on Nanotechnology Mediated - Herbal Drug Delivery for the
Treatment of Obesity |
|
| Dipthi Shree, Chinam Niranjan Patra, Biswa Mohan Sahoo | | The Natural Products Journal. 2024; 14(1) | | [Pubmed] | [DOI] | | 3 |
Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition |
|
| Urvashi Gupta, Dipak Maity, Virender K Sharma | | Biomedical Materials. 2024; 19(1): 012003 | | [Pubmed] | [DOI] | | 4 |
A Review on ZnO-based Targeted Drug Delivery System |
|
| Urvashi Chawla, David Dahiya, Yogesh Kumar, Anu Bala, Mahaveer Genwa, Nityananda Agasti, Sanjay Tandon, Surinder P. Singh, P. L. Meena | | Letters in Drug Design & Discovery. 2024; 21(3): 397 | | [Pubmed] | [DOI] | | 5 |
Auranofin-Loaded Chitosan Nanoparticles Demonstrate Potency against Triple-Negative Breast Cancer |
|
| Maame Abena O. Afrifa, Jong H. Kim, Kathryn A. Pitton, Chibuzor Olelewe, Adedamola S. Arojojoye, Douglas R. Strachan, Mark A. Suckow, Samuel G. Awuah | | ACS Applied Bio Materials. 2024; | | [Pubmed] | [DOI] | | 6 |
Trajectories of square lattice staircase polygons |
|
| E J Janse van Rensburg | | Physica Scripta. 2023; 98(12): 125975 | | [Pubmed] | [DOI] | | 7 |
Blood–brain barrier disruption in dementia: Nano-solutions as new treatment options |
|
| Ceinwyn G. Cooper, Konstantinos N. Kafetzis, Adjanie Patabendige, Aristides D. Tagalakis | | European Journal of Neuroscience. 2023; | | [Pubmed] | [DOI] | | 8 |
Trajectories of directed lattice paths |
|
| EJ Janse van Rensburg | | Physica Scripta. 2023; 98(3): 035016 | | [Pubmed] | [DOI] | | 9 |
Fabrication and Applications of Polymeric Nanoparticles for Herbal Drug
Delivery and Targeting |
|
| Dipthi Shree, Chinam N. Patra, Biswa M. Sahoo | | Current Traditional Medicine. 2023; 9(5) | | [Pubmed] | [DOI] | | 10 |
Emerging Applications of Polymeric Nanoparticles in Tumor Targeting |
|
| Minakshi Gupta Marwaha, Rajendra Awasthi, Rakesh Kumar Marwaha, Parteek Prasher, Monica Gulati, Sachin Kumar Singh, Krishnan Anand, Gaurav Gupta, Dinesh Kumar Chellappan, Kamal Dua, Harish Dureja | | Current Nanoscience. 2023; 19(5): 677 | | [Pubmed] | [DOI] | | 11 |
Quality by Design Enabled Systematic Optimization of Calcineurin Inhibitor
loaded Polymeric Nanoparticles for Sustained Topical Delivery in Psoriasis |
|
| Priyanka Ahlawat, Shruti Patel, Abhay Dharmasi, Asha Patel | | Current Drug Therapy. 2023; 18(3): 218 | | [Pubmed] | [DOI] | | 12 |
The escape transition in a self-avoiding walk model of linear polymers |
|
| E J Janse van Rensburg | | Journal of Physics A: Mathematical and Theoretical. 2023; 56(34): 345004 | | [Pubmed] | [DOI] | | 13 |
Surface Modification of Poly(lactide-co-glycolide) Nanoparticles for the Sustained in
vitro Release and the Enhanced Cytotoxicity of Chelidonine |
|
| Zahra Hamidia, Kahin Shahanipour, Nasrin Talebian, Ramesh Monajemi | | Anti-Cancer Agents in Medicinal Chemistry. 2023; 23(15): 1774 | | [Pubmed] | [DOI] | | 14 |
Preparation and characterization of particle-filled microgels by ion induction based on zein and ?-carrageenan for delivering the CoQ10 |
|
| Meijuan Liao, Ruyi Zhang, Yi Zhou, Duoxia Xu, Yahong Han, Fuguo Liu, Jiaqi Su, Shuai Chen | | Food Hydrocolloids. 2023; 142: 108774 | | [Pubmed] | [DOI] | | 15 |
Skin targeting by chitosan/hyaluronate hybrid nanoparticles for the management of irritant contact dermatitis: In vivo therapeutic efficiency in mouse-ear dermatitis model |
|
| Khaled E. Abuelella, Hend Abd-Allah, Sara M. Soliman, Mona M.A. Abdel-Mottaleb | | International Journal of Biological Macromolecules. 2023; 232: 123458 | | [Pubmed] | [DOI] | | 16 |
Rationally designed nanoparticulate delivery approach for silymarin with natural bio-enhancer: In vitro characterization and in vivo evaluations of hepatoprotective effects in a mouse model |
|
| Ashwini Kumar Mishra, S.L. Neha, Laxmi Rani, Ankit Jain, Hitesh Kumar Dewangan, Pravat Kumar Sahoo | | Journal of Drug Delivery Science and Technology. 2023; : 104580 | | [Pubmed] | [DOI] | | 17 |
Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy |
|
| Neha Singh, Disha Marwaha, Shalini Gautam, Nikhil Rai, Pratiksha Tiwari, Madhu Sharma, Ravi Prakash Shukla, Madhav Nilakanth Mugale, Akhilesh Kumar, Prabhat Ranjan Mishra | | Biomacromolecules. 2023; | | [Pubmed] | [DOI] | | 18 |
Nanoparticles: Taking a Unique Position in Medicine |
|
| Tomy Muringayil Joseph, Debarshi Kar Mahapatra, Amin Esmaeili, Lukasz Piszczyk, Mohamed S. Hasanin, Mashhoor Kattali, Józef Haponiuk, Sabu Thomas | | Nanomaterials. 2023; 13(3): 574 | | [Pubmed] | [DOI] | | 19 |
Formulation of Methotrexate Loaded Solid Lipid Nanoparticles By Micro
Emulsion Technique |
|
| Abbaraju Krishnasailaja, Ayesha Siddiqua Gazi | | Current Nanomaterials. 2023; 8(2): 153 | | [Pubmed] | [DOI] | | 20 |
Curcumin Release from Biomaterials for Enhanced Tissue Regeneration Following Injury or Disease |
|
| Adelle E. Hamilton, Ryan J. Gilbert | | Bioengineering. 2023; 10(2): 262 | | [Pubmed] | [DOI] | | 21 |
A Review on Diverging approaches to Fabricate Polymeric Nanoparticles |
|
| Shivani Deshmukh, Bharati Chaudhari, Atish Velhal, Vivekkumar Redasani | | Asian Journal of Research in Pharmaceutical Sciences. 2022; : 341 | | [Pubmed] | [DOI] | | 22 |
A Compendious Review on Biodegradable Polymeric Nanoparticles |
|
| Shivani Deshmukh, Bharati Chaudhari, Atish Velhal, Vivekkumar Redasani | | Asian Journal of Pharmacy and Technology. 2022; : 371 | | [Pubmed] | [DOI] | | 23 |
Chitosan/Gamma-Alumina/Fe3O4@5-FU Nanostructures as Promising Nanocarriers: Physiochemical Characterization and Toxicity Activity |
|
| Narges Ajalli, Mehrab Pourmadadi, Fatemeh Yazdian, Hamid Rashedi, Mona Navaei-Nigjeh, Ana M. Díez-Pascual | | Molecules. 2022; 27(17): 5369 | | [Pubmed] | [DOI] | | 24 |
An Overview of Nanotechnologies for Drug Delivery to the Brain |
|
| Ahsan Ayub, Shawn Wettig | | Pharmaceutics. 2022; 14(2): 224 | | [Pubmed] | [DOI] | | 25 |
QbD Supported Optimization of the Alginate-Chitosan Nanoparticles of Simvastatin in Enhancing the Anti-Proliferative Activity against Tongue Carcinoma |
|
| Waleed Y. Rizg, N. Raghavendra Naveen, Mallesh Kurakula, Haitham A. Bukhary, Awaji Y. Safhi, Eman Alfayez, Amal M. Sindi, Sarah Ali, Samar S. Murshid, Khaled M. Hosny | | Gels. 2022; 8(2): 103 | | [Pubmed] | [DOI] | | 26 |
Nanopolymers in drug delivery system |
|
| Mamta Saiyad, Nimish Shah | | Materials Today: Proceedings. 2022; 67: 25 | | [Pubmed] | [DOI] | | 27 |
Polymer based nanoparticles for BCS class II drugs -“A mini Review” |
|
| Karishma Mahajan, Nishant Thakur, Manish Goswami, kundal simran, Isha Arora | | Materials Today: Proceedings. 2022; | | [Pubmed] | [DOI] | | 28 |
Particle engineering in dry powders for inhalation |
|
| Regina Scherließ, Simon Bock, Nicholas Bungert, Anna Neustock, Lena Valentin | | European Journal of Pharmaceutical Sciences. 2022; : 106158 | | [Pubmed] | [DOI] | | 29 |
Nanosponge Approach -A Plethora of Opportunities as a Promising
Nanocarrier for Novel Drug Delivery |
|
| Shah Esha Bhavin, Gajjar Anuradha | | Recent Patents on Nanotechnology. 2022; 16(4): 271 | | [Pubmed] | [DOI] | | 30 |
Novel Herbal Nanocarriers for Treatment of Dermatological Disorders |
|
| Dipthi Shree, Chinam Niranjan Patra, Biswa Mohan Sahoo | | Pharmaceutical Nanotechnology. 2022; 10(4): 246 | | [Pubmed] | [DOI] | | 31 |
Virus as a Nanocarrier for Drug Delivery Redefining Medical
Therapeutics - A Status Report |
|
| Sanjay Kumar Ojha, Ritesh Pattnaik, Puneet Kumar Singh, Shubha Dixit, Snehasish Mishra, Sreyasi Pal, Subrat Kumar | | Combinatorial Chemistry & High Throughput Screening. 2022; 25(10): 1619 | | [Pubmed] | [DOI] | | 32 |
Microgels and Nanogels for the Delivery of Poorly Water-Soluble Drugs |
|
| Ridhdhi Dave, Gurpreet Randhawa, Daeun Kim, Madeline Simpson, Todd Hoare | | Molecular Pharmaceutics. 2022; 19(6): 1704 | | [Pubmed] | [DOI] | | 33 |
Nanodrugs against cancer: biological considerations in its redesign |
|
| P. A. Flores de los Rios, R. G. Casañas Pimentel, E. San Martín Martínez | | International Journal of Polymeric Materials and Polymeric Biomaterials. 2022; : 1 | | [Pubmed] | [DOI] | | 34 |
Preparation of Ethanol Extract of Propolis Loaded Niosome Formulation and Evaluation of Effects on Different Cancer Cell Lines |
|
| Emel Oyku Cetin,Derya Selcen Salmanoglu,Ilknur Ozden,Gizem Ors-Kumoglu,Sibel Akar,Melis Demirozer,Fatih Karabey,Kubilay Dogan Kilic,Levent Kirilmaz,Yigit Uyanikgil,Canan Sevimli-Gur | | Nutrition and Cancer. 2021; : 1 | | [Pubmed] | [DOI] | | 35 |
Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors |
|
| Bharat Kumar Reddy Sanapalli,Vidyasrilekha Yele,Srikanth Jupudi,Veera Venkata Satyanarayana Reddy Karri | | RSC Advances. 2021; 11(43): 26820 | | [Pubmed] | [DOI] | | 36 |
Recent progress in nanotechnology-based drug carriers for celastrol delivery |
|
| Ling Guo,Yongping Zhang,Khuloud T. Al-Jamal | | Biomaterials Science. 2021; | | [Pubmed] | [DOI] | | 37 |
Beta-d-glucan-based drug delivery system and its potential application in targeting tumor associated macrophages |
|
| Yuting Su,Lei Chen,Fan Yang,Peter C.K. Cheung | | Carbohydrate Polymers. 2021; 253: 117258 | | [Pubmed] | [DOI] | | 38 |
Ceftriaxone sodium loaded onto polymer-lipid hybrid nanoparticles enhances antibacterial effect on gram-negative and gram-positive bacteria: Effects of lipid - polymer ratio on particles size, characteristics, in vitro drug release and antibacterial drug efficacy |
|
| Arash Rigi Hossein abadi,Nafiseh Farhadian,Mohammad Karimi,Samaneh Porozan | | Journal of Drug Delivery Science and Technology. 2021; : 102457 | | [Pubmed] | [DOI] | | 39 |
Herbal medicine for ocular diseases: An age old therapy and its future perspective |
|
| Archana S. Pokkalath, Apurva Sawant, Sujata P. Sawarkar | | Journal of Drug Delivery Science and Technology. 2021; : 102979 | | [Pubmed] | [DOI] | | 40 |
Effects of a tiny particle trapped in a spherical cavity on fluid structure, contact density, and capillary condensation (A DFT Approach) |
|
| Ezat Keshavarzi, Abbas Helmi, Samaneh Safdaar | | Journal of Molecular Liquids. 2021; : 118314 | | [Pubmed] | [DOI] | | 41 |
Recent Advances in Nanomaterials for Dermal and Transdermal Applications |
|
| Amani Zoabi,Elka Touitou,Katherine Margulis | | Colloids and Interfaces. 2021; 5(1): 18 | | [Pubmed] | [DOI] | | 42 |
Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications |
|
| Anastasia Kyriakoudi,Eleni Spanidi,Ioannis Mourtzinos,Konstantinos Gardikis | | Plants. 2021; 10(6): 1238 | | [Pubmed] | [DOI] | | 43 |
Lipoidal-Nano Architecture for Parental Drug Delivery: Formulation Development and Regulatory Concerns |
|
| Vikas Jhawat, Anil Kumar Sharma, Vandana Garg, Monika Gulia , Rohit Dutt | | Current Applied Polymer Science. 2021; 4(1): 31 | | [Pubmed] | [DOI] | | 44 |
A Statistical Study on the Development of Metronidazole-Chitosan-Alginate Nanocomposite Formulation Using the Full Factorial Design |
|
| Hazem Abdul Kader Sabbagh,Samer Hasan Hussein-Al-Ali,Mohd Zobir Hussein,Zead Abudayeh,Rami Ayoub,Suha Mujahed Abudoleh | | Polymers. 2020; 12(4): 772 | | [Pubmed] | [DOI] | | 45 |
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology |
|
| Aleksandra Zielinska,Filipa Carreiró,Ana M. Oliveira,Andreia Neves,Bárbara Pires,D. Nagasamy Venkatesh,Alessandra Durazzo,Massimo Lucarini,Piotr Eder,Amélia M. Silva,Antonello Santini,Eliana B. Souto | | Molecules. 2020; 25(16): 3731 | | [Pubmed] | [DOI] | | 46 |
Alginate Nanoformulation: Influence of Process and Selected Variables |
|
| Hazem Choukaife,Abd Almonem Doolaanea,Mulham Alfatama | | Pharmaceuticals. 2020; 13(11): 335 | | [Pubmed] | [DOI] | | 47 |
Poly(ethyl acrylate-co-methyl Methacrylate-co-trimethylammoniethyl methacrylate chloride) (Eudragit RS100) Nanocapsules as Nanovector Carriers for Phoenix dactylifera L. Seeds Oil: a Versatile Antidiabetic Agent |
|
| Narimane Lammari,Francesca Froiio,Mehdi Louaer,Maria Chiara Cristiano,Chawki Bensouici,Donatella Paolino,Ouahida Louaer,Abdeslam Hassen Meniai,Abdelhamid Elaissari | | Biomacromolecules. 2020; | | [Pubmed] | [DOI] | | 48 |
Chitosan-alginate nanoparticles as effective oral carriers to improve the stability, bioavailability, and cytotoxicity of curcumin diethyl disuccinate |
|
| Feuangthit Niyamissara Sorasitthiyanukarn,Chawanphat Muangnoi,Pornchai Rojsitthisak,Pranee Rojsitthisak | | Carbohydrate Polymers. 2020; : 117426 | | [Pubmed] | [DOI] | | 49 |
Microbial acetylcholinesterase inhibitors for Alzheimer’s therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery |
|
| Amira G. Zaki,El-Sayed R. El-Sayed,M. Abd Elkodous,Gharieb S. El-Sayyad | | Applied Microbiology and Biotechnology. 2020; | | [Pubmed] | [DOI] | | 50 |
Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment |
|
| Atefeh Yassemi,Soheila Kashanian,Hossein Zhaleh | | Pharmaceutical Development and Technology. 2020; : 1 | | [Pubmed] | [DOI] | | 51 |
A Critical Review of Biological Properties, Delivery Systems and Analytical/Bioanalytical Methods for Determination of Bevacizumab |
|
| Leonardo Delello Di Filippo,Karen Cristina dos Santos,Gilmar Hanck-Silva,Felipe Tita de Lima,Maria Palmira Daflon Gremião,Marlus Chorilli | | Critical Reviews in Analytical Chemistry. 2020; : 1 | | [Pubmed] | [DOI] | | 52 |
Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis |
|
| Salma A. Fereig,Ghada M. El-Zaafarany,Mona G. Arafa,Mona M. A. Abdel-Mottaleb | | Drug Delivery. 2020; 27(1): 662 | | [Pubmed] | [DOI] | | 53 |
Multicomponent Nanocomposites for Complex Anticancer Therapy: Effect of Aggregation Processes on Their Efficacy |
|
| Nataliya Kutsevol,Yuliia Kuziv,Tetiana Bezugla,Vasyl Chumachenko,Vasyl Chekhun | | International Journal of Polymer Science. 2020; 2020: 1 | | [Pubmed] | [DOI] | | 54 |
Experimental Approach to the Creation of Efficient Multicomponent Nanocomposites for Antitumor Therapy |
|
| N. Kutsevol,Y. Kuziv,V. Chumachenko,O. Nadtoka,L. Bulavin,V. Chekhun | | Ukrainian Journal of Physics. 2020; 65(8): 678 | | [Pubmed] | [DOI] | | 55 |
Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease |
|
| Prasad Minakshi,Rajesh Kumar,Mayukh Ghosh,Basanti Brar,Manju Barnela,Preeti Lakhani | | Current Topics in Medicinal Chemistry. 2020; 20(11): 982 | | [Pubmed] | [DOI] | | 56 |
Polymer - Metal Nanocomplexes Based Delivery System: A Boon for Agriculture Revolution |
|
| Pawan Kaur,Rita Choudhary,Anamika Pal,Chanchal Mony,Alok Adholeya | | Current Topics in Medicinal Chemistry. 2020; 20(11): 1009 | | [Pubmed] | [DOI] | | 57 |
The Potential Anticancer Activity of 5-Fluorouracil Loaded in Cellulose Fibers Isolated from Rice Straw |
|
| Mostafa Yusefi,Kamyar Shameli,Hossein Jahangirian,Sin-Yeang Teow,Hiroshi Umakoshi,Bahram Saleh,Roshanak Rafiee-moghaddam,Thomas J Webster | | International Journal of Nanomedicine. 2020; Volume 15: 5417 | | [Pubmed] | [DOI] | | 58 |
In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery |
|
| Akhlesh K. Jain,Suresh Thareja | | Artificial Cells, Nanomedicine, and Biotechnology. 2019; 47(1): 524 | | [Pubmed] | [DOI] | | 59 |
Formulation of Pioglitazone-Eudragit® RS100 Nanobeads and Nanofibers Using Electrospraying Technique |
|
| Giovanni Khosro Adibkia,Mohammad Barzegar-Jalali,Niloofar Balaei,Karim Osouli-Bostanabad,Solmaz Ghajar,Shahram Emami,Solmaz Zakhireh | | Polymer Science, Series A. 2019; | | [Pubmed] | [DOI] | | 60 |
Preparation and Evaluation of Chitosan Loaded Naproxen Nanoparticles by Emulsion Interfacial Reaction Method |
|
| Abbaraju Krishna Sailaja,Juveria Banu | | Drug Delivery Letters. 2019; 9(2): 89 | | [Pubmed] | [DOI] | | 61 |
Gelatin nanoparticles loaded methylene blue as a candidate for photodynamic antimicrobial chemotherapy applications in Candida albicans growth |
|
| Jéssica Aparecida Ribeiro Ambrosio,Bruna Cristina dos Santos Pinto,Daniele da Silva Godoy,Janicy Arantes Carvalho,Alexandro da Silva Abreu,Bruna Graziele Marques da Silva,Leonardo de Carvalho Leonel,Maricilia Silva Costa,Milton Beltrame Junior,Andreza Ribeiro Simioni | | Journal of Biomaterials Science, Polymer Edition. 2019; 30(14): 1356 | | [Pubmed] | [DOI] | | 62 |
New Advanced Strategies for the Treatment of Lysosomal Diseases Affecting the Central Nervous System |
|
| Maria R. Gigliobianco,Piera Di Martino,Siyuan Deng,Cristina Casadidio,Roberta Censi | | Current Pharmaceutical Design. 2019; 25(17): 1933 | | [Pubmed] | [DOI] | | 63 |
Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives |
|
| Arun K. Ketabat,Arun K. Pundir,Arun K. Mohabatpour,Arun K. Lobanova,Arun K. Koutsopoulos,Arun K. Hadjiiski,Arun K. Chen,Arun K. Papagerakis,Arun K. Papagerakis | | Pharmaceutics. 2019; 11(7): 302 | | [Pubmed] | [DOI] | | 64 |
Ionic Liquid-Polymer Nanoparticle Hybrid Systems as New Tools to Deliver Poorly Soluble Drugs |
|
| Ana Júlio,Rita Caparica,Sofia A. Costa Lima,Ana Sofia Fernandes,Catarina Rosado,Duarte M. F. Prazeres,Salette Reis,Tânia Santos de Almeida,Pedro Fonte | | Nanomaterials. 2019; 9(8): 1148 | | [Pubmed] | [DOI] | | 65 |
Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System |
|
| Farah Shahjin,Subhash Chand,Sowmya V. Yelamanchili | | Journal of Neuroimmune Pharmacology. 2019; | | [Pubmed] | [DOI] | | 66 |
Enhancing Curcumin Oral Bioavailability Through Nanoformulations |
|
| Vinod S. Ipar,Anisha Dsouza,Padma V. Devarajan | | European Journal of Drug Metabolism and Pharmacokinetics. 2019; | | [Pubmed] | [DOI] | | 67 |
Development of ionic liquid-polymer nanoparticle hybrid systems for delivery of poorly soluble drugs |
|
| Ana Júlio,Sofia A. Costa Lima,Salette Reis,Tânia Santos de Almeida,Pedro Fonte | | Journal of Drug Delivery Science and Technology. 2019; | | [Pubmed] | [DOI] | | 68 |
Acaricidal efficacy of deltamethrin-zinc oxide nanocomposite on Rhipicephalus (Boophilus) annulatus tick |
|
| Waleed M. Arafa,Asmaa N. Mohammed,Fatma I. Abo El-Ela | | Veterinary Parasitology. 2019; 268: 36 | | [Pubmed] | [DOI] | | 69 |
Gold Nanoclusters Embedded Mucin Nanoparticles for Photodynamic Therapy and Bioimaging |
|
| Deepanjalee Dutta,Sunil Kumar Sailapu,Anitha T Simon,Siddhartha Sankar Ghosh,Arun Chattopadhyay | | Langmuir. 2019; | | [Pubmed] | [DOI] | | 70 |
Regeneration of Cochlear Hair Cells and Hearing Recovery through Hes1 Modulation with siRNA Nanoparticles in Adult Guinea Pigs |
|
| Xiaoping Du,Qunfeng Cai,Matthew B. West,Ibrahima Youm,Xiangping Huang,Wei Li,Weihua Cheng,Don Nakmali,Donald L. Ewert,Richard D. Kopke | | Molecular Therapy. 2018; | | [Pubmed] | [DOI] | | 71 |
Cancer chemotherapy: Effect of poloxamer modified nanoparticles on cellular function |
|
| Grace Lovia Allotey-Babington,Henry Nettey,Sucheta D’Sa,Kimberly Braz Gomes,Martin J. DæSouza | | Journal of Drug Delivery Science and Technology. 2018; | | [Pubmed] | [DOI] | | 72 |
State-of-art based approaches for anticancer drug-targeting to nucleus |
|
| Rahul Tiwari,Priyanka Jain,Saket Asati,Tanweer Haider,Vandana Soni,Vikas Pandey | | Journal of Drug Delivery Science and Technology. 2018; 48: 383 | | [Pubmed] | [DOI] | | 73 |
Intranasal Drug Delivery of Frovatriptan Succinate–Loaded Polymeric Nanoparticles for Brain Targeting |
|
| Deepika Deepika,Hitesh Kumar Dewangan,Lakshmi Maurya,Sanjay Singh | | Journal of Pharmaceutical Sciences. 2018; | | [Pubmed] | [DOI] | | 74 |
Nanoengineered delivery systems for cancer imaging and therapy: recent advances, future directions and patent evaluation |
|
| Ghazal Nabil,Ketki Bhise,Samaresh Sau,Mohamed Atef,Hossny A. El-Banna,Arun K. Iyer | | Drug Discovery Today. 2018; | | [Pubmed] | [DOI] | | 75 |
Nanoparticles Carrying Biological Molecules: Recent Advances and Applications |
|
| Suryani Saallah,I. Wuled Lenggoro | | KONA Powder and Particle Journal. 2018; | | [Pubmed] | [DOI] | | 76 |
Polymer-Stabilized Micelles Reduce the Drug Rapid Clearance In Vivo |
|
| Shan-Ni Wen,Chih-Hang Chu,Yu-Chao Wang,Hsin-Ying Huang,Yu-Jing Wang,Jia-Yi Lin,Hsiao-Ting Lu,Sin-Jie Wang,Chung-Shi Yang | | Journal of Nanomaterials. 2018; 2018: 1 | | [Pubmed] | [DOI] | | 77 |
Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules |
|
| María Francisca Matus,Martín Ludueña,Cristian Vilos,Iván Palomo,Marcelo M Mariscal | | Beilstein Journal of Nanotechnology. 2018; 9: 1328 | | [Pubmed] | [DOI] | | 78 |
Controlled release of an endostatin peptide using chitosan nanoparticles |
|
| Sanaz Ebrahimi Samani,Zahra Seraj,Hossein Naderimanesh,Khosro Khajeh,Ahmad Reza Esmaeili Rastaghi,Taher Droudi,Peirhosein Kolivand,Hadi Kazemi,S. Mohsen Asghari | | Chemical Biology & Drug Design. 2017; | | [Pubmed] | [DOI] | | 79 |
NANOTECHNOLOGY AS A POTENTIAL THERAPEUTIC ALTERNATIVE FOR SCHISTOSOMIASIS |
|
| Fernanda Tomiotto-Pellissier,Milena Menegazzo Miranda-Sapla,Laís Fernanda Machado,Bruna Taciane da Silva Bortoleti,Claudia Stoeglehner Sahd,Alan Ferreira Chagas,João Paulo Assolini,Francisco José de Abreu Oliveira,Wander Rogério Pavanelli,Ivete Conchon-Costa,Idessania Nazareth Costa,Francine Nesello Melanda | | Acta Tropica. 2017; | | [Pubmed] | [DOI] | | 80 |
Self-assembled chitosan-alginate polyplex nanoparticles containing temoporfin |
|
| Ingrid Brezaniova,Jiri Trousil,Zulfiya Cernochova,Vladimir Kral,Martin Hruby,Petr Stepanek,Miroslav Slouf | | Colloid and Polymer Science. 2017; | | [Pubmed] | [DOI] | | 81 |
Enhancement of 5-aminolevulinic acid phototoxicity by encapsulation in polysaccharides based nanocomplexes for photodynamic therapy application |
|
| Antonio Di Martino,Alena Pavelkova | | Journal of Photochemistry and Photobiology B: Biology. 2017; | | [Pubmed] | [DOI] | | 82 |
Exploitation of chemical, herbal and nanoformulated acaricides to control the cattle tick, Rhipicephalus ( Boophilus ) microplus – A review |
|
| Balan Banumathi,Baskaralingam Vaseeharan,Periyannan Rajasekar,Narayanan Marimuthu Prabhu,Palaniappan Ramasamy,Kadarkarai Murugan,Angelo Canale,Giovanni Benelli | | Veterinary Parasitology. 2017; 244: 102 | | [Pubmed] | [DOI] | | 83 |
PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity |
|
| A.L. Silva,P.C. Soema,B. Slütter,F. Ossendorp,W. Jiskoot | | Human Vaccines & Immunotherapeutics. 2016; : 00 | | [Pubmed] | [DOI] | | 84 |
Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment |
|
| David Howard,Jetzabel Garcia-Parra,Gareth D. Healey,Cynthia Amakiri,Lavinia Margarit,Lewis W. Francis,Deyarina Gonzalez,R. Steven Conlan | | Interface Focus. 2016; 6(6): 20160054 | | [Pubmed] | [DOI] | | 85 |
Polymers in Drug Delivery |
|
| Apurva Srivastava,Tejaswita Yadav,Soumya Sharma,Anjali Nayak,Akanksha Akanksha Kumari,Nidhi Mishra | | Journal of Biosciences and Medicines. 2016; 04(01): 69 | | [Pubmed] | [DOI] | | 86 |
A review of nanotechnology with an emphasis on Nanoplex |
|
| Rupali Nanasaheb Kadam,Raosaheb Sopanrao Shendge,Vishal Vijay Pande | | Brazilian Journal of Pharmaceutical Sciences. 2015; 51(2): 255 | | [Pubmed] | [DOI] | | 87 |
Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy |
|
| Simeon K. Adesina,Emmanuel O. Akala | | Molecular Pharmaceutics. 2015; 12(12): 4175 | | [Pubmed] | [DOI] | | 88 |
Deformation and fracture of nano-sized metal-coated polymer particles: A molecular dynamics study |
|
| Jianyang Wu,Shijo Nagao,Zhiliang Zhang,Jianying He | | Engineering Fracture Mechanics. 2015; 150: 209 | | [Pubmed] | [DOI] | |
|
|
|
|